Position in BHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$923,812
-$215,037 QoQ
Shares Held
187,386
-11.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$2,580
PutShares
400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. BHC ranks #29 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,415,471 | $101,715,746 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
260,605 | $43,922,366 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
2,649,866 | $38,396,558 | |
| 4 | ALKS |
Alkermes plc.
|
655,140 | $34,329,336 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
300,967 | $33,389,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
58,580 | $31,740,401 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,180,709 | $29,057,248 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
437,192 | $27,958,428 |
All Filings in BHC
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $923,812 | 187,386 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,138,849 | 210,898 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $369,990 | 53,236 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $8,494,308 | 1,316,947 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $2,580 | 400 | Put | Defined | 2025-11-13 | |
| 2025-06-30 | $19,980,333 | 3,000,050 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,235 | 500 | Put | Defined | 2025-05-14 | |
| 2025-03-31 | $19,501,647 | 3,014,165 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $24,148,767 | 2,996,125 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $6,077 | 754 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $24,538,539 | 3,007,174 | Shares | Defined | 2024-11-13 | |
| 2024-09-30 | $2,072 | 254 | Put | Defined | 2024-11-13 | |
| 2024-06-30 | $1,770 | 254 | Put | Defined | 2024-08-13 | |
| 2024-06-30 | $22,811,241 | 3,272,775 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,694 | 254 | Put | Defined | 2024-05-01 | |
| 2024-03-31 | $31,918,529 | 3,008,344 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $24,203,269 | 3,017,864 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $2,037 | 254 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $24,802,222 | 3,017,302 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $24,145,120 | 3,018,140 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $24,431,082 | 3,016,183 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $109,485 | 17,434 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $121,022 | 17,565 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $2,121,023 | 253,711 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,792,657 | 253,508 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $9,730,260 | 352,418 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,738,950 | 349,693 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $4,304,381 | 146,807 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $10,800,741 | 340,288 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $343,491 | 16,514 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $978,584 | 62,972 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $1,122,420 | 61,368 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $252,681 | 16,302 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||